XML 89 R58.htm IDEA: XBRL DOCUMENT v3.26.1
Significant events for the years ended December 31, 2023, 2024 and 2025 and subsequent events - For the year ended 2023 (Details)
€ / shares in Units, $ / shares in Units, € in Thousands, $ in Millions
1 Months Ended 6 Months Ended 12 Months Ended 30 Months Ended 145 Months Ended
Jul. 28, 2025
€ / shares
shares
Nov. 02, 2023
EUR (€)
Oct. 24, 2023
EUR (€)
€ / shares
shares
Oct. 24, 2023
USD ($)
shares
Aug. 24, 2023
EUR (€)
Aug. 22, 2023
EUR (€)
Aug. 21, 2023
EUR (€)
Aug. 20, 2023
EUR (€)
transaction
€ / shares
May 24, 2023
€ / shares
shares
Feb. 22, 2023
EUR (€)
€ / shares
shares
Jul. 30, 2021
EUR (€)
€ / shares
shares
Oct. 31, 2020
shares
Dec. 31, 2023
shares
plan
€ / shares
Dec. 31, 2025
EUR (€)
shares
€ / shares
Dec. 31, 2024
EUR (€)
€ / shares
shares
Dec. 31, 2023
EUR (€)
€ / shares
shares
Dec. 31, 2025
shares
€ / shares
Dec. 31, 2025
EUR (€)
€ / shares
Jul. 28, 2025
$ / shares
Nov. 19, 2024
€ / shares
Oct. 24, 2023
$ / shares
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares                   € 130,000       € 637,462   € 353,377          
Capital increase from issuance of ordinary shares (in shares) | shares     20,325,500 20,325,500           20,000,000       11,679,400   40,325,500          
Par value per share (in euro per share) | € / shares     € 0.01           € 0.01 € 0.01     € 0.01 € 0.01 € 0.01 € 0.01 € 0.01 € 0.01   € 0.01  
Equity issuance, subscripion price per share (in euro per share) | € / shares                   € 6.50                      
Share issue related cost                               € 28,111          
Exercises of share warrants (in shares) | shares                       464,309     4,000            
Proceeds from borrowings                                   € 175,000      
Repayments of convertible loan notes         € 33,000                 € 2,188 € 8,750 27,188          
Capital increases     € 223,300 $ 235.8                   € 648,124 € 0 353,377   € 1,194,700      
Capital increases     202,000 212.2                                  
Payments for share issue costs     € 21,300 $ 23.6                                  
Total AGAs                                          
Disclosure of detailed information about borrowings [line items]                                          
Number of share-based compensation plans issued | plan                         5                
Number of instruments issued (in shares) | shares                         2,601,296 6,280,727     10,828,148        
ADS                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares (in shares) | shares 11,679,400   18,699,460 18,699,460                                  
Number of shares received per ADS (in shares) | shares     1 1                                  
Issue of equity, offering price per share (in dollar/euro per share) | $ / shares                                     $ 64.00   $ 11.60
Ordinary shares                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares (in shares) | shares     1,626,040 1,626,040                                  
Issue of equity, offering price per share (in dollar/euro per share) | € / shares € 54.58   € 10.9864                                    
Kreos 1, convertible bond loans, tranche A                                          
Disclosure of detailed information about borrowings [line items]                                          
Number of other share warrants repurchased (in shares) | shares                 43,070                        
Exercises of share warrants (in shares) | shares                 67,887                        
Kreos 1, convertible bond loans, tranche B                                          
Disclosure of detailed information about borrowings [line items]                                          
Number of other share warrants repurchased (in shares) | shares                 43,070                        
Exercises of share warrants (in shares) | shares                 31,696                        
Repayments of convertible loan notes         8,000   € 7,661                            
Kreos & Claret financing                                          
Disclosure of detailed information about borrowings [line items]                                          
Borrowings, maximum borrowing capacity               € 75,000                          
Aggregate exercise price         4,000                                
Kreos & Claret financing | Kreos C BSA                                          
Disclosure of detailed information about borrowings [line items]                                          
Issuance of other share warrants   € 4,000                                      
Kreos & Claret financing | Maximum                                          
Disclosure of detailed information about borrowings [line items]                                          
Aggregate exercise price               € 8,000                          
Heights convertible notes                                          
Disclosure of detailed information about borrowings [line items]                                          
Equity issuance, subscripion price per share (in euro per share) | € / shares               € 14.4303                          
Borrowings, maximum borrowing capacity               € 75,000                          
Proceeds from borrowings         35,000                                
Heights convertible notes | Maximum                                          
Disclosure of detailed information about borrowings [line items]                                          
Equity issuance, subscripion price per share (in euro per share) | € / shares               € 14.4303                          
Kreos & Claret convertible notes (OCABSA)                                          
Disclosure of detailed information about borrowings [line items]                                          
Proceeds from borrowings           € 25,000                              
OCEANE                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares (in shares) | shares                     1,964,031                    
Equity issuance, subscripion price per share (in euro per share) | € / shares                     € 30.55                    
Repayments of convertible loan notes         25,102                     25,000          
Capital increases                     € 60,000                    
Kreos & Claret financing and Heights convertible notes                                          
Disclosure of detailed information about borrowings [line items]                                          
Proceeds from borrowings, net of refinancing of existing indebteness         € 27,000                                
Share premium                                          
Disclosure of detailed information about borrowings [line items]                                          
Capital increase from issuance of ordinary shares                           € 637,345   € 352,974          
€130.0 million cross-over financing, february 2023                                          
Disclosure of detailed information about borrowings [line items]                                          
Financial agreement, amount                   € 130,000                      
Capital increase from issuance of ordinary shares                   € 130,000                      
Capital increase from issuance of ordinary shares (in shares) | shares                   20,000,000                      
Par value per share (in euro per share) | € / shares                   € 0.01                      
Equity issuance, subscripion price per share (in euro per share) | € / shares                   € 6.50                      
€130.0 million cross-over financing, february 2023 | Share premium                                          
Disclosure of detailed information about borrowings [line items]                                          
Share issue related cost                   € 6,700                      
€49.2 million cross-over financing, september 2022                                          
Disclosure of detailed information about borrowings [line items]                                          
Equity issuance, percentage of current share capital                   89.60%                      
€150.0 million financing, august 2023                                          
Disclosure of detailed information about borrowings [line items]                                          
Financial agreement, amount               € 150,000                          
Financial agreement, number of transactions | transaction               2